Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇳🇿NZ · Medicine#4010K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
5K to 15K🎙 ~2x weekly·112 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
10K to 30K🇳🇿100% - Active Followers
Loyal subscribers who consistently listen
4K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Federal Funding in Otolaryngology–Head and Neck Surgery
Apr 9, 2026
13m 18s
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma
Mar 26, 2026
11m 33s
Why Hearing Health Must Be Part of Voice Biomarker Research
Jan 2, 2026
14m 20s
Biofeedback vs Respiratory Retraining for Inducible Laryngeal Obstruction
Dec 11, 2025
16m 11s
Evaluation of Practice Patterns for 6-Sinus Balloon Sinus Dilation
Nov 13, 2025
19m 07s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/9/26 |  Federal Funding in Otolaryngology–Head and Neck Surgery✨ | federal fundingotolaryngology+3 | Matthew G. Crowson, MD, MPA, MASc, MBI | Federal Funding in Otolaryngology–Head and Neck Surgery—When It Mattered | — | federal fundingotolaryngology+5 | — | 13m 18s | |
| 3/26/26 |  Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma✨ | Adenoid Cystic CarcinomaAmivantamab+3 | Trisha M. Wise-Draper, MD, PhD | Amivantamab for Recurrent or Metastatic Adenoid Cystic CarcinomaAmivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial | — | Adenoid Cystic CarcinomaAmivantamab+3 | — | 11m 33s | |
| 1/2/26 |  Why Hearing Health Must Be Part of Voice Biomarker Research✨ | hearing healthvoice biomarker research+3 | Victoria A. SanchezYaël Bensoussan | Why Hearing Health Must Be Part of Voice Biomarker Research | — | hearing healthvoice biomarker+3 | — | 14m 20s | |
| 12/11/25 |  Biofeedback vs Respiratory Retraining for Inducible Laryngeal Obstruction✨ | biofeedbackrespiratory retraining+3 | Molly N. Huston, MDWilliam A. Strober, MD, MSCI | JAMA Network | — | biofeedbackrespiratory retraining+5 | — | 16m 11s | |
| 11/13/25 |  Evaluation of Practice Patterns for 6-Sinus Balloon Sinus Dilation✨ | Balloon Sinus DilationSinus Surgery+3 | Kristine A. Smith, MDJay F. Piccirillo, MD+1 | JAMA Network | — | Balloon Sinus DilationSinus Surgery+3 | — | 19m 07s | |
| 10/16/25 |  The JAMA Otolaryngology-Head & Neck Surgery Editorial Fellowship Experience✨ | editorial fellowshipotolaryngology+4 | Melina J. Windon, MDPeter Dixon, MD, MSc | JAMA Otolaryngology-Head & Neck SurgeryJAMA Network | — | editorial fellowshipotolaryngology+4 | — | 8m 54s | |
| 10/9/25 |  Anteroposterior and Lateral Epiglottis-Related Obstruction in Adult Obstructive Sleep Apnea✨ | obstructive sleep apneaepiglottis obstruction+3 | Eric J. Kezirian, MD, MPH | Anteroposterior and Lateral Epiglottis-Related Obstruction in Adult Obstructive Sleep Apnea | — | obstructive sleep apneaepiglottis+3 | — | 11m 34s | |
| 8/14/25 |  Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia✨ | COVID-19parosmia+3 | Nyssa Fox Farrell, MDLara W. Crock, MD, PhD, MSCI | Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia | — | stellate ganglion blockCOVID-19+5 | — | 19m 42s | |
| 7/31/25 |  Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab✨ | HPV-Negative HNSCCNeoadjuvant Nivolumab+4 | Jennifer M. Johnson, MD, PhDAdam J. Luginbuhl, MD | A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab | — | HNSCCNivolumab+4 | — | 17m 45s | |
| 6/12/25 |  Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer✨ | financial toxicityquality of life+3 | Leila J. Mady, MD, PhD, MPH | Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer | — | financial toxicityquality of life+3 | — | 14m 15s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/15/25 |  Impact of Hearing Aid Service Model and Technology on Patient Outcomes | Interview with Yu-Hsiang Wu, MD, PhD and Todd Ricketts, PhD, authors of Impact of Hearing Aid Service Model and Technology on Patient Outcomes:A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Hearing Aid Service Models, Technology, and Patient Outcomes | — | ||||||
| 4/24/25 |  Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma | Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma | — | ||||||
| 3/20/25 |  Over-the-Counter Hearing Aid–Enabled Earbuds | Interview with Alexander Chern, MD, author of Over-the-Counter Hearing Aid–Enabled Earbuds—Merging Hearing Health and Technology. Hosted by Paul C. Bryson, MD, MBA. Related Content: Over-the-Counter Hearing Aid–Enabled Earbuds—Merging Hearing Health and Technology | — | ||||||
| 3/6/25 |  Gene Therapy for Hearing Loss | Interview with Oliver F. Adunka, MD, MBA, and Vinay K. Rathi, MD, MBA, authors of Gene Therapy for Hearing Loss–Will the Price be Right? Hosted by Paul C. Bryson, MD, MBA. Related Content: Gene Therapy for Hearing Loss—Will the Price be Right? | — | ||||||
| 2/6/25 |  Manual Therapy for Fibrosis-Related Late Effect Dysphagia in HNC Survivors | Interview with Katherine A. Hutcheson, PhD, author of Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Nonrandomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors | — | ||||||
| 1/23/25 |  Consensus Statement on Trial Design for Airway Stenosis: Third NoAAC Proceedings | Interview with Ruth J. Davis, MD, author of Third Proceedings of The North American Airway Collaborative (NoAAC): Consensus Statement on Trial Design for Airway Stenosis. Hosted by Paul C. Bryson, MD, MBA. Related Content: Third Proceedings of The North American Airway Collaborative (NoAAC) | — | ||||||
| 11/14/24 |  Peripartum and Pregnancy-Related Considerations in Residency | Interview with Robbi A. Kupfer, MD, Nadine I. Ibrahim, MD, and Janice L. Farlow, MD, PhD, authors of Peripartum and Pregnancy-Related Considerations in Residency. Hosted by Paul C. Bryson, MD MBA. Related Content: Peripartum and Pregnancy-Related Considerations in Residency | — | ||||||
| 10/10/24 |  Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfunction | Interview with S. A. Reza Nouraei, BChir, PhD, author of Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfunction—The Overwhelmed Vagus Hypothesis. Hosted by Paul C. Bryson, MD, MBA. Related Content: Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfunction—The Overwhelmed Vagus Hypothesis | — | ||||||
| 9/26/24 |  Everolimus Following Dilation in Idiopathic Subglottic Stenosis | Interview with Alexander T. Hillel, MD, author of Oral Everolimus Following Dilation in Idiopathic Subglottic Stenosis: A Phase 1 Nonrandomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Oral Everolimus Following Dilation in Idiopathic Subglottic Stenosis | — | ||||||
| 8/22/24 |  Surgery-Related Considerations in Treating People Who Use Cannabis | Interview with Mark M. Mims, MD, author of Surgery-Related Considerations in Treating People Who Use Cannabis: A Review. Hosted by Paul C. Bryson, MD, MBA. Related Content: Surgery-Related Considerations in Treating People Who Use Cannabis | — | ||||||
| 5/30/24 |  Highlights From the American Head and Neck Society Annual Meeting at COSM 2024 | Combined Otolaryngology Spring Meetings Chair Patrick Ha, MD, and Co-Chairs Nicole C. Schmitt, MD, and Sidharth V. Puram, MD, PhD, share late-breaking research from the annual Combined Otolaryngology Spring Meetings in an interview hosted by JAMA Otolaryngology Web Editor Paul C. Bryson, MD, MBA, and JAMA Otolaryngology Deputy Editor Samir Khariwala, MD, MS. Related Content: Outcomes of Conversion Surgery for Patients With Low-Risk Papillary Thyroid Carcinoma Active Surveillance and Conversion Surgery for Low-Risk Thyroid Cancer—The Disconnect Between Literature and Practice Oropharyngeal Cancer Staging Health Record Extraction Using Artificial Intelligence | — | ||||||
| 5/23/24 |  Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring | Interview with Jay F. Piccirillo, MD, and Azadeh Afshari, DDS, authors of Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring: A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Mandibular Advancement vs Combined Airway and Positional Therapy for Snoring | — | ||||||
| 4/25/24 |  Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer | Interview with Evan M. Graboyes, MD, MPH, author of Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer | — | ||||||
| 3/7/24 |  The Future of Endoscopic Endonasal Surgical Navigation | Interview with Garret W. Choby, MD, author of Navigating the Nose—The Future of Endoscopic Endonasal Surgical Navigation. Hosted by Paul C. Bryson, MD, MBA. Related Content: Navigating the Nose—The Future of Endoscopic Endonasal Surgical Navigation | — | ||||||
| 2/22/24 |  Voice as an AI Biomarker of Health—Introducing Audiomics | Interview with Yaël Bensoussan, MD, MSc, and Anaïs Rameau, MD, MPhil, authors of Voice as an AI Biomarker of Health—Introducing Audiomics. Hosted by Paul C. Bryson, MD, MBA. Related Content: Voice as an AI Biomarker of Health—Introducing Audiomics | — | ||||||
Showing 25 of 112
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.